Opthea Interest Expense Over Time
| OPT Stock | USD 3.69 0.36 10.81% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Opthea Performance and Opthea Correlation. Opthea |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opthea. If investors know Opthea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opthea listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.76) | Quarterly Revenue Growth (0.68) | Return On Assets (0.83) | Return On Equity (33.83) |
The market value of Opthea is measured differently than its book value, which is the value of Opthea that is recorded on the company's balance sheet. Investors also form their own opinion of Opthea's value that differs from its market value or its book value, called intrinsic value, which is Opthea's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opthea's market value can be influenced by many factors that don't directly affect Opthea's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opthea's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opthea is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opthea's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Interest Expense Analysis
Compare Opthea and related stocks such as Molecular Partners, MediciNova, and Anebulo Pharmaceuticals Interest Expense Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MOLN | 226.5 K | 226.5 K | 226.5 K | 226.5 K | 853 | 216 | 89 K | 197 K | 591 K | 27 K | 271 K | 548 K | 605 K | 49 K | 46.5 K |
| MNOV | 0.0 | 1.6 M | 0.0 | 0.0 | 628 | 514 | 454 | 298 | 0.0 | 1.1 M | 322.8 K | 84.1 K | 562.4 K | 646.7 K | 679.1 K |
| ANEB | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 1.3 K | 11.8 K | 7.3 K | 0.0 | 151.2 K | 158.8 K |
| CSBR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 39 K | 712 K | 71 K | 24 K | 24 K | 27.6 K | 38.3 K |
| AVTE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 75 K | 65 K | 1.8 M | 2 M | 2.1 M |
| ADAG | 91.1 K | 91.1 K | 91.1 K | 91.1 K | 91.1 K | 91.1 K | 91.1 K | 91.1 K | 91.1 K | 138.1 K | 138.1 K | 363.8 K | 693.3 K | 1.1 M | 1.2 M |
| ACRV | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 59 K | 1.5 M | 1.7 M | 1.8 M |
| RZLT | 0.0 | 0.0 | 568.9 K | 4.2 M | 6.7 K | 5 K | 1.6 K | 689.2 K | 5 M | 12 K | 375 K | 1.8 M | 919 K | 1.1 M | 1.2 M |
| ANTX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3 K | 69 K | 514 K | 591.1 K | 620.7 K |
| INBX | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 M | 1.5 M | 5.7 M | 10.8 M | 5.2 M | 16.1 M | 31.8 M | 33.4 M |
| MLYS | 115 K | 115 K | 115 K | 115 K | 115 K | 115 K | 115 K | 115 K | 115 K | 115 K | 115 K | 27 K | 1.7 M | 1.9 M | 2 M |
Opthea and related stocks such as Molecular Partners, MediciNova, and Anebulo Pharmaceuticals Interest Expense description
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.My Equities
My Current Equities and Potential Positions
| Opthea | OPT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Australia |
| Exchange | NASDAQ Exchange |
USD 3.69
Additional Tools for Opthea Stock Analysis
When running Opthea's price analysis, check to measure Opthea's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opthea is operating at the current time. Most of Opthea's value examination focuses on studying past and present price action to predict the probability of Opthea's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opthea's price. Additionally, you may evaluate how the addition of Opthea to your portfolios can decrease your overall portfolio volatility.